Diversified Price Sales Ratio from 2010 to 2024

DHCNL Stock  USD 15.41  0.79  4.88%   
Diversified Healthcare Price Sales Ratio yearly trend continues to be quite stable with very little volatility. The value of Price Sales Ratio is projected to decrease to 0.60. From the period between 2010 and 2024, Diversified Healthcare, Price Sales Ratio regression line of its data series had standard deviation of  2.36 and standard deviation of  2.36. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
0.6333699
Current Value
0.6
Quarterly Volatility
2.36194514
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Diversified Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Diversified Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 304.6 M, Selling General Administrative of 30.3 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 0.0102 or PTB Ratio of 0.36. Diversified financial statements analysis is a perfect complement when working with Diversified Healthcare Valuation or Volatility modules.
  
Check out the analysis of Diversified Healthcare Correlation against competitors.

Latest Diversified Healthcare's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Diversified Healthcare Trust over the last few years. It is Diversified Healthcare's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Diversified Healthcare's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Diversified Price Sales Ratio Regression Statistics

Arithmetic Mean3.17
Geometric Mean1.97
Coefficient Of Variation74.45
Mean Deviation2.04
Median3.46
Standard Deviation2.36
Sample Variance5.58
Range7.2687
R-Value(0.93)
Mean Square Error0.86
R-Squared0.86
Slope(0.49)
Total Sum of Squares78.10

Diversified Price Sales Ratio History

2023 0.63
2022 0.12
2021 0.53
2020 0.6
2019 1.93
2018 2.49
2017 4.23

About Diversified Healthcare Financial Statements

Diversified Healthcare investors utilize fundamental indicators, such as Price Sales Ratio, to predict how Diversified Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price Sales Ratio 0.63  0.60 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Diversified Healthcare is a strong investment it is important to analyze Diversified Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Diversified Healthcare's future performance. For an informed investment choice regarding Diversified Stock, refer to the following important reports:
Check out the analysis of Diversified Healthcare Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Diversified Healthcare. If investors know Diversified will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Diversified Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.68)
Revenue Per Share
6.324
Quarterly Revenue Growth
0.541
Return On Assets
0.0124
Return On Equity
(0.06)
The market value of Diversified Healthcare is measured differently than its book value, which is the value of Diversified that is recorded on the company's balance sheet. Investors also form their own opinion of Diversified Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Diversified Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Diversified Healthcare's market value can be influenced by many factors that don't directly affect Diversified Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Diversified Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Diversified Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Diversified Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.